Aspirin Articles
Bayer and Onyx halt Nexavar trial
28 April 2009
URCH study foresees more pharma mega-mergers
27 April 2009
Positive HCC data for Y-90 radioembolization
24 April 2009
Boehringer's 2008 net sales jump 6.4%
24 April 2009
Novartis' 1st-qtr 2009 results boosted by new products
24 April 2009
Daiichi/Lilly's Efient gets first world launch in UK - first new antiplatelet drug in a decade
9 April 2009
Stock Commentary - Europe - week to Aug 15
8 April 2009
Japan stock market week to April 6, 2009
7 April 2009
Teva gets FDA appro for generic Yaz
3 April 2009
Stock Commentary - Europe - week to mar 30, 2009
2 April 2009
Solvay viewing options for pharma
2 April 2009
Archemix initiates Ph II anti-VWF drug trial
2 April 2009
Bayer launches DTP scheme in UK
1 April 2009
Afinitor cleared in USA for advanced RCC
1 April 2009
Aspirin more effective with Plavix in AF
1 April 2009
Bayer Yakuhin aiming for $2.06B annual sales
31 March 2009
Stock Commentary - Europe - week to March 23, 2009
30 March 2009
Licorice extract blocks CRC growth in mice
30 March 2009
Sutent cleared for UK kidney cancer patients
30 March 2009
Pradaxa Ph III stroke program nears end
30 March 2009
Levitra extends erection time up to three times
30 March 2009
Bayer to launch MS drug in titration pack
27 March 2009
Ferring promotes Paul Korner to SVP of FIPCUS
23 March 2009
Stock Commentary - Europe - week to Mar 16, 2009
23 March 2009
S-P's TRA meets Ph II study endpoints
23 March 2009
Bayer drops 10% ahead of rivaroxaban review
23 March 2009
New guidelines for blood cancer therapy
23 March 2009
USPSTF underscores regular aspirin use
23 March 2009
GW soars 51% on positive data from 3rd Ph III Sativex study; EU submission set for 2nd qtr
23 March 2009
Folate supps "double prostate cancer risk"
16 March 2009
Bayer Technology Services opens office in India
16 March 2009
Shire launches Fosrenol in Japan
16 March 2009
Major pharmacy reforms in Sweden
16 March 2009
NICE gives nod to Bayer's Xarelto
16 March 2009
Bayer Schering Pharma named and shamed over UK Code
9 March 2009
Nexavar pushes Onyx back to profit
9 March 2009
Stock Commentary - Europe - week to Feb 23, 2009
2 March 2009
Bayer cleared to begin UK trials of riociguat
23 February 2009
Drugmakers remain attractive employers in Belgium
23 February 2009
Bayer must retract television adverts for Yaz to settle law suit
16 February 2009
Bayer to establish R&D facility in Beijing
16 February 2009
Bayer takes riociguat into Phase III
16 February 2009
ED drugmakers accused of price-fixing in Switzerland
16 February 2009
Affimed gets 550K euro grant from MITI initiative
16 February 2009
Aspirin cuts risk of gastric cancer 36%
16 February 2009
Sutent available in England, not Scotland
9 February 2009
Schering-Plough finally back in profit after Organon buy; exceeds expectations, pleasing shareholders
9 February 2009
Stock Commentary - Europe - week to Jan 19, 2009
26 January 2009
1876 article may point to cheap diabetes drug
26 January 2009
Highlights of first PDCO meeting of 2009
26 January 2009
Cumberland names Barry Lee as product director
19 January 2009
Stock Commentary - Europe - week to Jan 19, 2009
19 January 2009
Bayer pays Micromet $6M for option on Ab
19 January 2009
Pharma/biotech mergers and acquisitions in 2008
12 January 2009
Bayer signs PET deal with Hamamatsu
12 January 2009
Stock Commentary - Europe - week to Jan 5, 2009
12 January 2009
Bayer's Visanne submitted for EU approval
12 January 2009
Bayer sues Abbott for slice of Humira earnings
12 January 2009
Bayer updates press on current pipeline
12 January 2009
Stock Commentary - Europe - week to Dec 15, 2008
22 December 2008
Bayer chairman calls for R&D tax breaks
22 December 2008
Free morning-after pill for UK
22 December 2008
Bayer's pipeline will protect it from credit crunch, no need to diversify; says chairman
22 December 2008
ASH hears strong data on Novartis
22 December 2008
Stock Commentary - Europe - week to Dec 8, 2008
15 December 2008
Scottish regulators give nod to Bayer's Xarelto, Wyeth's Relistor and B-MS' Reyataz
15 December 2008
Pooled RECORD data "confirm Xarelto better than Lovenox"
15 December 2008
Bayer signs deal for ProStrakan's Tostrex
15 December 2008
Spectrum and Cell Therapeutics form JV for projected expansion in US sales of Zevalin
8 December 2008
ProStrakan licenses Tostran to Bayer
1 December 2008
Boehringer opens new Japanese R&D center
1 December 2008
Pfizer withdraws OTC Viagra EU application
1 December 2008
Bayer pays out $97.5M to settle kick-back allegations
1 December 2008
Stock Commentary - Europe - week to Nov 17, 2008
24 November 2008
Govts pay for good drugs, says Bayer chief
24 November 2008
Bayer pledges 1.5M euros to China hemophilia centers
24 November 2008
Evotec's nine-month loss narrows 12.6%
24 November 2008
TorreyPines confirms Evelyn Graham as CEO
17 November 2008
Immunogen names James O
17 November 2008
Stock Commentary - Europe - week to Nov 10, 2008
17 November 2008
Pozen's coated aspirin tablet shows less GI damage
17 November 2008
deCODE presents AF test data at AHA
17 November 2008
Bayer presents results of Xarelto trial at AHA
17 November 2008
SYGNIS raises 18.2M euros via capital increase
17 November 2008
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
